Cholesterol and lipoprotein levels as predictors of response to interferon for hepatitis C [3]

Annals of Internal Medicine

Volumn 133, Issue 11, 2000, Pages 921-

  Toyoda, H ^a   Kumada, T ^a  

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERFERON; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; HEPATITIS C; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOTHERAPY; LETTER; LIVER FIBROSIS; MAJOR CLINICAL STUDY; PREDICTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0034610319     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-133-11-200012050-00022     Document Type: Letter

References (4)

1. Serum cholesterol and low-density lipoprotein cholesterol levels as predictors of response to interferon therapy for chronic hepatitis C
2. Effect of daily administration period of natural alpha-interferon in patients with chronic hepatitis C
3. Serum lipid and lipoprotein patterns in patients with liver cirrhosis and chronic active hepatitis
4. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis